<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00470158</url>
  </required_header>
  <id_info>
    <org_study_id>H.22.05.03.11.C2</org_study_id>
    <secondary_id>GHS-A-00-03-00019-00-90027844</secondary_id>
    <nct_id>NCT00470158</nct_id>
  </id_info>
  <brief_title>Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes</brief_title>
  <official_title>Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins Bloomberg School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>International Centre for Diarrhoeal Disease Research, Bangladesh</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>United States Agency for International Development (USAID)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins Bloomberg School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the long-term public health goal of developing an effective micronutrient
      supplementation program to improve child health by improving iron and zinc status and
      decreasing morbidity due to diarrhea in areas with high rates of childhood malnutrition, we
      seek to determine the most efficacious method of decreasing childhood morbidity and mortality
      due to diarrhea in toddlers by re-examining the issue of iron and zinc interaction and
      determining if this interaction can be minimized by separate administration of iron and zinc
      supplementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Iron supplementation is used in reducing anemia and improving hemoglobin status. Zinc
      supplementation is emerging as possibly an efficacious preventive measure in decreasing
      incidence of severe diarrhea. Previous studies have suggested interactions of zinc and iron
      when given together, reducing the effects of supplementation with both minerals. One study in
      Peru has shown a decrease in interaction effect with separate supplementation of iron and
      zinc in time when compared to iron administration alone or placebo; however, an evaluation of
      clinical outcomes and zinc or iron status when iron and zinc are administered separately
      compared to supplementation of zinc and iron together or each alone has not previously been
      done. This trial will assess the effect of iron and zinc supplementation given on alternate
      days compared with giving them together in a combined supplement.

      We propose a randomized, double blind, placebo-controlled community trial of children 6-23
      months in Mirzapur, Bangladesh. We will recruit and enroll 1000 children 6-23 months old who
      are permanent residents of the selected villages. Each child will be randomly assigned to 1)
      daily alternating zinc and placebo 2) daily alternating iron/folic acid and placebo 3) daily
      alternating zinc/iron/folic acid and placebo 4) daily alternating zinc and iron/folic acid 5)
      daily placebo. Primary outcomes will include incidence of severe diarrhea, evaluated weekly
      for 6 months, hemoglobin, prevalence of anemia, and serum zinc.

      Analysis of the data will be done to compare the effect of separate iron and zinc
      supplementation as compared to combined iron and zinc supplementation as well as compared to
      iron, zinc, or placebo single supplementation. We will evaluate the difference in incidence
      rate of severe diarrhea, serum hemoglobin, percent anemia, and serum zinc. Since this will be
      a randomized, double-blind, placebo controlled trial, differences in effect will be most
      likely explained by the timing of supplement doses. If there is an improvement in clinical
      and biochemical outcomes, this would be consistent with a decreased interaction of
      absorption. If no difference is found, there may be another mechanism for the seeming
      interaction of iron and zinc besides that of mutually inhibitory absorption in the intestine.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2007</start_date>
  <completion_date type="Actual">February 2008</completion_date>
  <primary_completion_date type="Actual">February 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Diarrhea</measure>
    <time_frame>6 months</time_frame>
    <description>A diarrhea episode was defined as three or more loose, liquid, or watery stools for 2 consecutive days, separated in time from an earlier or subsequent episode by at least 2 consecutive diarrhea-free days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Hemoglobin</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Zinc Status</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent Anemic</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>5</number_of_arms>
  <enrollment type="Actual">1000</enrollment>
  <condition>Anemia</condition>
  <condition>Diarrhea</condition>
  <condition>Iron</condition>
  <arm_group>
    <arm_group_label>combined iron and zinc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron and zinc together</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Separate iron and zinc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron and zinc on separate days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iron alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Iron</description>
  </arm_group>
  <arm_group>
    <arm_group_label>zinc alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Zinc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>iron and zinc combined</intervention_name>
    <description>Children &gt;= 12 months received an average of 5mg zinc/day, 6.25 Iron/day, and 25IU folic acid/day. children&lt;12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.</description>
    <arm_group_label>combined iron and zinc</arm_group_label>
    <other_name>Tablets were manufactured by Nutriset</other_name>
    <other_name>S.A.S. (Malaunay, France).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>iron and zinc on separate days</intervention_name>
    <description>Children &gt;= 12 months received an average of 5mg zinc/day, alternating daily with 6.25 Iron/day, and 25IU folic acid/day. Children&lt;12 received half that dose. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.</description>
    <arm_group_label>Separate iron and zinc</arm_group_label>
    <other_name>Tablets were manufactured by Nutriset</other_name>
    <other_name>S.A.S. (Malaunay, France).</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>iron</intervention_name>
    <description>Children &gt;= 12 months received an average 6.25 Iron/day, and 25IU folic acid/day. Children&lt;12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.</description>
    <arm_group_label>iron alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc</intervention_name>
    <description>Children &gt;= 12 months received an average of 5mg zinc/day. Children&lt;12 received half that dose. This dose was alternated daily with placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.</description>
    <arm_group_label>zinc alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <description>Children received daily placebo. Dissolvable doses were distributed in blister packs and reconstituted with a teaspoon of water. Doses were administered in the morning. For missed doses, the mother gave the child the next morning dose, and a second dose in the evening.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children 6-18 months old

          -  Permanent residents of the selected villages

        Exclusion Criteria:

          -  Severe malnutrition requiring hospitalization (defined as weight for height &lt;-3 SD
             Z-score)

          -  Severe anemia requiring treatment (hemoglobin &lt; 70 g/L)

          -  Chronic illness that would impair feeding ability

          -  Likely to move in next 6 months.

          -  Fever greater than 38.5

          -  Regular iron supplementation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>18 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert E Black, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins Bloomberg School of Public Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>ICDDR,B</name>
      <address>
        <city>Dhaka</city>
        <state>Mohakhali</state>
        <zip>1212</zip>
        <country>Bangladesh</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Bangladesh</country>
  </location_countries>
  <results_reference>
    <citation>Chang S, El Arifeen S, Bari S, Wahed MA, Rahman KM, Rahman MT, Mahmud AB, Begum N, Zaman K, Baqui AH, Black RE. Supplementing iron and zinc: double blind, randomized evaluation of separate or combined delivery. Eur J Clin Nutr. 2010 Feb;64(2):153-60. doi: 10.1038/ejcn.2009.127. Epub 2009 Nov 11.</citation>
    <PMID>19904293</PMID>
  </results_reference>
  <verification_date>December 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 3, 2007</study_first_submitted>
  <study_first_submitted_qc>May 3, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 7, 2007</study_first_posted>
  <results_first_submitted>August 10, 2011</results_first_submitted>
  <results_first_submitted_qc>August 10, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 19, 2011</results_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>zinc</keyword>
  <keyword>iron</keyword>
  <keyword>interaction</keyword>
  <keyword>diarrhea</keyword>
  <keyword>delivery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diarrhea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Iron</mesh_term>
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>All 6â€“18 month old permanent residents of selected villages near Kumudini Hospital were enrolled from May 8, 2007-August 31, 2007.</recruitment_details>
      <pre_assignment_details>If one family had two eligible children, one was randomly selected for enrollment. Children with severe malnutrition (weight for height z-score -3 s.d.), severe anemia (hemoglobin &lt;70 g/l), chronic illnesses that would impair feeding ability, planned move during the study period, or active fever (&gt;38.5 C) were excluded from the study.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Combined Iron and Zinc</title>
          <description>combined iron and zinc, alternating daily with placebo</description>
        </group>
        <group group_id="P2">
          <title>Separate Iron and Zinc</title>
          <description>iron, alternating daily with zinc</description>
        </group>
        <group group_id="P3">
          <title>Iron Alone</title>
          <description>iron, alternating daily with placebo</description>
        </group>
        <group group_id="P4">
          <title>Zinc Alone</title>
          <description>zinc, alternating daily with placebo</description>
        </group>
        <group group_id="P5">
          <title>Placebo</title>
          <description>placebo daily</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="201">9 children received wrong samples at enrollment and were analyzed by the supplement received.</participants>
                <participants group_id="P2" count="199">9 children received wrong samples at enrollment and were analyzed by the supplement received.</participants>
                <participants group_id="P3" count="201">9 children received wrong samples at enrollment and were analyzed by the supplement received.</participants>
                <participants group_id="P4" count="198">9 children received wrong samples at enrollment and were analyzed by the supplement received.</participants>
                <participants group_id="P5" count="201">9 children received wrong samples at enrollment and were analyzed by the supplement received.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="193">Enrolled for at least 90% of total study time.</participants>
                <participants group_id="P2" count="191">Enrolled for at least 90% of total study time.</participants>
                <participants group_id="P3" count="193">Enrolled for at least 90% of total study time.</participants>
                <participants group_id="P4" count="193">Enrolled for at least 90% of total study time.</participants>
                <participants group_id="P5" count="195">Enrolled for at least 90% of total study time.</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="8"/>
                <participants group_id="P3" count="8"/>
                <participants group_id="P4" count="5"/>
                <participants group_id="P5" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
                <participants group_id="P5" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Combined Iron and Zinc</title>
          <description>combined iron and zinc, alternating daily with placebo</description>
        </group>
        <group group_id="B2">
          <title>Separate Iron and Zinc</title>
          <description>iron, alternating daily with zinc</description>
        </group>
        <group group_id="B3">
          <title>Iron Alone</title>
          <description>iron, alternating daily with placebo</description>
        </group>
        <group group_id="B4">
          <title>Zinc Alone</title>
          <description>zinc, alternating daily with placebo</description>
        </group>
        <group group_id="B5">
          <title>Placebo</title>
          <description>placebo daily</description>
        </group>
        <group group_id="B6">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="201"/>
            <count group_id="B2" value="199"/>
            <count group_id="B3" value="201"/>
            <count group_id="B4" value="198"/>
            <count group_id="B5" value="201"/>
            <count group_id="B6" value="1000"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="201"/>
                    <measurement group_id="B2" value="199"/>
                    <measurement group_id="B3" value="201"/>
                    <measurement group_id="B4" value="198"/>
                    <measurement group_id="B5" value="201"/>
                    <measurement group_id="B6" value="1000"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                    <measurement group_id="B6" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.93" spread="0.31"/>
                    <measurement group_id="B2" value="0.925" spread="0.32"/>
                    <measurement group_id="B3" value="0.9" spread="0.33"/>
                    <measurement group_id="B4" value="0.925" spread="0.33"/>
                    <measurement group_id="B5" value="0.9" spread="0.32"/>
                    <measurement group_id="B6" value="0.92" spread="0.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="87"/>
                    <measurement group_id="B2" value="107"/>
                    <measurement group_id="B3" value="93"/>
                    <measurement group_id="B4" value="109"/>
                    <measurement group_id="B5" value="88"/>
                    <measurement group_id="B6" value="484"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="114"/>
                    <measurement group_id="B2" value="92"/>
                    <measurement group_id="B3" value="108"/>
                    <measurement group_id="B4" value="89"/>
                    <measurement group_id="B5" value="113"/>
                    <measurement group_id="B6" value="516"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Bangladesh</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="201"/>
                    <measurement group_id="B2" value="199"/>
                    <measurement group_id="B3" value="201"/>
                    <measurement group_id="B4" value="198"/>
                    <measurement group_id="B5" value="201"/>
                    <measurement group_id="B6" value="1000"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Incidence of Diarrhea</title>
        <description>A diarrhea episode was defined as three or more loose, liquid, or watery stools for 2 consecutive days, separated in time from an earlier or subsequent episode by at least 2 consecutive diarrhea-free days.</description>
        <time_frame>6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Combined Iron and Zinc</title>
            <description>combined iron and zinc, alternating daily with placebo</description>
          </group>
          <group group_id="O2">
            <title>Separate Iron and Zinc</title>
            <description>iron, alternating daily with zinc</description>
          </group>
          <group group_id="O3">
            <title>Iron Alone</title>
            <description>iron, alternating daily with placebo</description>
          </group>
          <group group_id="O4">
            <title>Zinc Alone</title>
            <description>zinc, alternating daily with placebo</description>
          </group>
          <group group_id="O5">
            <title>Placebo</title>
            <description>placebo daily</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Diarrhea</title>
          <description>A diarrhea episode was defined as three or more loose, liquid, or watery stools for 2 consecutive days, separated in time from an earlier or subsequent episode by at least 2 consecutive diarrhea-free days.</description>
          <units>episodes</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="201"/>
                <count group_id="O2" value="199"/>
                <count group_id="O3" value="201"/>
                <count group_id="O4" value="198"/>
                <count group_id="O5" value="201"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="201"/>
                    <measurement group_id="O2" value="204"/>
                    <measurement group_id="O3" value="260"/>
                    <measurement group_id="O4" value="224"/>
                    <measurement group_id="O5" value="235"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Hemoglobin</title>
        <time_frame>6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Zinc Status</title>
        <time_frame>6 months</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Percent Anemic</title>
        <time_frame>6 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Combined Iron and Zinc</title>
          <description>combined iron and zinc, alternating daily with placebo</description>
        </group>
        <group group_id="E2">
          <title>Separate Iron and Zinc</title>
          <description>iron, alternating daily with zinc</description>
        </group>
        <group group_id="E3">
          <title>Iron Alone</title>
          <description>iron, alternating daily with placebo</description>
        </group>
        <group group_id="E4">
          <title>Zinc Alone</title>
          <description>zinc, alternating daily with placebo</description>
        </group>
        <group group_id="E5">
          <title>Placebo</title>
          <description>placebo daily</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="201"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="198"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>infectious hospitalizations</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="8" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="17" subjects_at_risk="201"/>
                <counts group_id="E4" subjects_affected="10" subjects_at_risk="198"/>
                <counts group_id="E5" subjects_affected="22" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="201"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="198"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>noninfectious hospitalizations</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="201"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="199"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="201"/>
                <counts group_id="E4" subjects_affected="4" subjects_at_risk="198"/>
                <counts group_id="E5" subjects_affected="4" subjects_at_risk="201"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Stephanie Chang</name_or_title>
      <organization>AHRQ</organization>
      <phone>301 427-1490</phone>
      <email>stephanie.chang@ahrq.hhs.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

